A Study of GWP42004 as Add on to Metformin in the Treatment of Participants With Type 2 Diabetes
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 207 participants.
Also called NCT02053272
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 207 participants
- Sponsor
- Jazz Pharmaceuticals
- Registry
-
NCT02053272 -
2013-001140-61
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Romania, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02053272. Randomized; quadruple masking; primary purpose treatment. Start 2014-02 (registry gives no type); primary completion 2016-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of GWP42004 as Add on to Metformin in the Treatment of Participants With Type 2 Diabetes
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- GWP42004
- Intervention (Drug)
- Placebo
- Lead sponsor
- Jazz Pharmaceuticals
Record details
- Record id
cardio:ct-nct02053272- Content hash
12594584e5526d6534f70e53a36d95fc323a701e5dcfa22d39469b916556b32d